Абстракт

Цели: The objective of this discussion is to explore both current and emerging treatment approaches for alopecia areata, with a focus on evaluating the effectiveness and potential risks of each option. Emphasis will be placed on carefully selecting the most appropriate treatment based on the patient’s condition and preferences to optimize outcomes. Additionally, the latest consensus from European dermatologists will be discussed to provide insight into new advancements and guidelines in the field Введение: Alopecia areata is a chronic condition characterized by relapsing, nonscarring hair loss. Its clinical course can vary widely, with the possibility of spontaneous resolution, persistence, recurrence, or progression.. The unpredictability of alopecia areata, with its potential for recurrence or progression,causes emotional strain.Patients often experience uncertainty about the future, not knowing if or when their hair might grow back or fall out again. Managing alopecia areata requires a delicate personalized approach. Материалы / методы: This abstract is based on my extensive clinical experience in treating Alopecia Areata using both classic and innovative approaches. I have integrated insights from the European Dermatologists Society (EADV) guidelines, which play a crucial role in shaping evidence-based treatments. Additionally, I have reviewed and incorporated findings from recently published breakthrough articles, reflecting the latest advancements in the field. The methodology includes a comparative analysis of traditional methods and novel therapies, focusing on efficacy, safety, and patient outcomes. Заключение: Treatment strategies depend on the severity of the condition and the extent of hair loss. Initial therapies often include intralesional and topical corticosteroids, as well as topical immunotherapy. Systemic treatments, such as oral baricitinib, ritlecitinib, and other Janus kinase (JAK) inhibitors, show promise in addressing more advanced cases. Additional therapies include excimer laser therapy, platelet-rich plasma (PRP), and photochemotherapy. Each option will be explored in detail in this lecture!